Cargando…

Phosphate-Trapping Liposomes for Long-Term Management of Hyperphosphatemia

Hyperphosphatemia is a typical complication of end-stage renal disease, characterized by elevated and life-threatening serum phosphate levels. Hemodialysis does not enable sufficient clearance of phosphate, due to slow cell-to-plasma kinetics of phosphate ions; moreover, dietary restrictions and con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzror-Azankot, Chen, Anaki, Adi, Sadan, Tamar, Motiei, Menachem, Popovtzer, Rachela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654424/ https://www.ncbi.nlm.nih.gov/pubmed/36363372 http://dx.doi.org/10.3390/ma15217779

Ejemplares similares

Optimization of Gold Nanorod Features for the Enhanced Performance of Plasmonic Nanocavity Arrays
por: Beiderman, Marianna, et al.
Publicado: (2021)

Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy
por: Gal, Omer, et al.
Publicado: (2022)

Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study
por: Reuveni, Tobi, et al.
Publicado: (2011)

Towards real-time detection of tumor margins using photothermal imaging of immune-targeted gold nanoparticles
por: Jakobsohn, Kobi, et al.
Publicado: (2012)

Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma
por: Hazkani, Inbal, et al.
Publicado: (2017)

A new method for cancer detection based on diffusion reflection measurements of targeted gold nanorods
por: Ankri, Rinat, et al.
Publicado: (2012)

Targeted Magnetic Nanoparticles for Mechanical Lysis of Tumor Cells by Low-Amplitude Alternating Magnetic Field
por: Vegerhof, Adi, et al.
Publicado: (2016)

Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles
por: Shamalov, Katerina, et al.
Publicado: (2021)

CT and MRI Imaging of Theranostic Bimodal Fe(3)O(4)@Au NanoParticles in Tumor Bearing Mice
por: Lipengolts, Alexey A., et al.
Publicado: (2022)

The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model
por: Shilo, Malka, et al.
Publicado: (2015)

Phosphate intake, hyperphosphatemia, and kidney function
por: Rubio-Aliaga, Isabel, et al.
Publicado: (2022)

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications
por: Betzer, Oshra, et al.
Publicado: (2015)

Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review
por: Fishbane, Steven N., et al.
Publicado: (2021)

Tmem174, a regulator of phosphate transporter prevents hyperphosphatemia
por: Sasaki, Sumire, et al.
Publicado: (2022)

Therapeutic Effect of Astroglia-like Mesenchymal Stem Cells Expressing Glutamate Transporter in a Genetic Rat Model of Depression
por: Shwartz, Amit, et al.
Publicado: (2017)

Randomized Study of Tenapanor Added to Phosphate Binders for Patients With Refractory Hyperphosphatemia
por: Nitta, Kosaku, et al.
Publicado: (2023)

Placenta-Derived Mesenchymal-like Adherent Stromal Cells as an Effective Cell Therapy for Cocaine Addiction in a Rat Model
por: Pe’er-Nissan, Hilla, et al.
Publicado: (2022)

Hyperphosphatemia Management in Patients with Chronic Kidney Disease
por: Shaman, Ahmed M., et al.
Publicado: (2016)

Hyperphosphatemia and Cardiovascular Disease
por: Zhou, Chao, et al.
Publicado: (2021)

Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis
por: Vasantha, J., et al.
Publicado: (2011)

Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
por: Palafox-Serdán, Frida, et al.
Publicado: (2020)

CT Imaging of Enzymatic Activity in Cancer Using Covalent Probes Reveal a Size-Dependent Pattern
por: Tsvirkun, Darya, et al.
Publicado: (2018)

Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study
por: Silva, Arnold L., et al.
Publicado: (2023)

Antibody‐mediated inhibition of EGFR reduces phosphate excretion and induces hyperphosphatemia and mild hypomagnesemia in mice
por: Ortega, Bernardo, et al.
Publicado: (2017)

The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients
por: Shigematsu, Takashi, et al.
Publicado: (2012)

Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia
por: Vallée, Michel, et al.
Publicado: (2021)

Effect of Intradialytic Exercise on Hyperphosphatemia and Malnutrition
por: Salhab, Nada, et al.
Publicado: (2019)

Control of hyperphosphatemia and maintenance of calcemia in CKD
por: Carvalho, Aluizio Barbosa, et al.
Publicado: (2021)

Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders
por: Goh, B. L., et al.
Publicado: (2018)

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
por: Shin, Sooyoung, et al.
Publicado: (2014)

Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective
por: Reddy, Yogesh NV, et al.
Publicado: (2014)

Patient education for hyperphosphatemia management: Improving outcomes while decreasing costs?
por: Karavetian, Mirey, et al.
Publicado: (2018)

Hyperphosphatemia is associated with high mortality in severe burns
por: Kuo, George, et al.
Publicado: (2018)

Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
por: Lenglet, Aurélie, et al.
Publicado: (2013)

Hyperphosphatemia: The hidden killer in chronic kidney disease
por: Askar, Akram M.
Publicado: (2015)

Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia
por: Koratala, Abhilash
Publicado: (2017)

Uremic Tumoral Calcinosis Resolved by Improvements in Hyperphosphatemia
por: Watanabe, Hirofumi, et al.
Publicado: (2017)

Non-occlusive Mesenteric Ischemia with Significant Hyperphosphatemia
por: Yamada, Aki, et al.
Publicado: (2022)

Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate
por: Persy, Veerle P, et al.
Publicado: (2009)

A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway
por: Wang, Joseph, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e5andhd0dei5ob9gk4hn92tq6m